Cargando…

A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry

BACKGROUND: Matrix-Assisted Laser-Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) has already proven to be a powerful tool for species identification in microbiological laboratories. As adequate and rapid screening methods for antibiotic resistance are crucially needed, the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaumann, Reiner, Knoop, Nicolas, Genzel, Gelimer H., Losensky, Kevin, Rosenkranz, Christiane, Stîngu, Catalina S., Schellenberger, Wolfgang, Rodloff, Arne C., Eschrich, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560646/
https://www.ncbi.nlm.nih.gov/pubmed/22936198
http://dx.doi.org/10.12659/MSM.883339
_version_ 1782257825784791040
author Schaumann, Reiner
Knoop, Nicolas
Genzel, Gelimer H.
Losensky, Kevin
Rosenkranz, Christiane
Stîngu, Catalina S.
Schellenberger, Wolfgang
Rodloff, Arne C.
Eschrich, Klaus
author_facet Schaumann, Reiner
Knoop, Nicolas
Genzel, Gelimer H.
Losensky, Kevin
Rosenkranz, Christiane
Stîngu, Catalina S.
Schellenberger, Wolfgang
Rodloff, Arne C.
Eschrich, Klaus
author_sort Schaumann, Reiner
collection PubMed
description BACKGROUND: Matrix-Assisted Laser-Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) has already proven to be a powerful tool for species identification in microbiological laboratories. As adequate and rapid screening methods for antibiotic resistance are crucially needed, the present study investigated the discrimination potential of MALDI-TOF MS among extended-spectrum-beta-lactamase (ESBL) or metallo-beta-lactamases- (MBL) producing and the nonproducing strains of Escherichia coli (n=19), Klebsiella pneumoniae (n=19), and Pseudomonas aeruginosa (n=38), respectively. MATERIAL/METHODS: We used a MALDI-TOF MS protocol, usually applied for species identification, in order to integrate a screening method for beta-lactamases into the routine species identification workflow. The acquired spectra were analyzed by visual inspection, statistical similarity analysis and support vector machine (SVM) classification algorithms. RESULTS: Neither visual inspection nor mathematical similarity analysis allowed discrimination between spectra of beta-lactamase-producing and the nonproducing strains, but classification within a species by SVM-based algorithms could achieve a correct classification rate of up to 70%. CONCLUSIONS: This shows that MALDI-TOF MS has definite potential to discriminate antibiotic-resistant strains due to ESBL and MBL production from nonproducing strains, but this performance is not yet sufficiently reliable for routine microbiological diagnostics.
format Online
Article
Text
id pubmed-3560646
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-35606462013-04-24 A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry Schaumann, Reiner Knoop, Nicolas Genzel, Gelimer H. Losensky, Kevin Rosenkranz, Christiane Stîngu, Catalina S. Schellenberger, Wolfgang Rodloff, Arne C. Eschrich, Klaus Med Sci Monit Diagnostics and Medical Technology BACKGROUND: Matrix-Assisted Laser-Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) has already proven to be a powerful tool for species identification in microbiological laboratories. As adequate and rapid screening methods for antibiotic resistance are crucially needed, the present study investigated the discrimination potential of MALDI-TOF MS among extended-spectrum-beta-lactamase (ESBL) or metallo-beta-lactamases- (MBL) producing and the nonproducing strains of Escherichia coli (n=19), Klebsiella pneumoniae (n=19), and Pseudomonas aeruginosa (n=38), respectively. MATERIAL/METHODS: We used a MALDI-TOF MS protocol, usually applied for species identification, in order to integrate a screening method for beta-lactamases into the routine species identification workflow. The acquired spectra were analyzed by visual inspection, statistical similarity analysis and support vector machine (SVM) classification algorithms. RESULTS: Neither visual inspection nor mathematical similarity analysis allowed discrimination between spectra of beta-lactamase-producing and the nonproducing strains, but classification within a species by SVM-based algorithms could achieve a correct classification rate of up to 70%. CONCLUSIONS: This shows that MALDI-TOF MS has definite potential to discriminate antibiotic-resistant strains due to ESBL and MBL production from nonproducing strains, but this performance is not yet sufficiently reliable for routine microbiological diagnostics. International Scientific Literature, Inc. 2012-09-01 /pmc/articles/PMC3560646/ /pubmed/22936198 http://dx.doi.org/10.12659/MSM.883339 Text en © Med Sci Monit, 2012 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
spellingShingle Diagnostics and Medical Technology
Schaumann, Reiner
Knoop, Nicolas
Genzel, Gelimer H.
Losensky, Kevin
Rosenkranz, Christiane
Stîngu, Catalina S.
Schellenberger, Wolfgang
Rodloff, Arne C.
Eschrich, Klaus
A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry
title A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry
title_full A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry
title_fullStr A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry
title_full_unstemmed A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry
title_short A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry
title_sort step towards the discrimination of beta-lactamase-producing clinical isolates of enterobacteriaceae and pseudomonas aeruginosa by maldi-tof mass spectrometry
topic Diagnostics and Medical Technology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560646/
https://www.ncbi.nlm.nih.gov/pubmed/22936198
http://dx.doi.org/10.12659/MSM.883339
work_keys_str_mv AT schaumannreiner asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry
AT knoopnicolas asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry
AT genzelgelimerh asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry
AT losenskykevin asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry
AT rosenkranzchristiane asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry
AT stingucatalinas asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry
AT schellenbergerwolfgang asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry
AT rodloffarnec asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry
AT eschrichklaus asteptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry
AT schaumannreiner steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry
AT knoopnicolas steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry
AT genzelgelimerh steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry
AT losenskykevin steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry
AT rosenkranzchristiane steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry
AT stingucatalinas steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry
AT schellenbergerwolfgang steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry
AT rodloffarnec steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry
AT eschrichklaus steptowardsthediscriminationofbetalactamaseproducingclinicalisolatesofenterobacteriaceaeandpseudomonasaeruginosabymalditofmassspectrometry